vimarsana.com

SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032

Card image cap

Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about SYNAGIS for Respiratory syncytial virus (RSV) in the seven major markets. A detailed picture of the SYNAGIS for RSV in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019-2032 is provided in this report

Related Keywords

United Kingdom , United States , Germany , Japan , Dublin , Ireland , Italy , France , Spain , , Clinical Development , Market Insight , Topics Covered , Marketed Therapies , Late Stage Emerging Therapies , Synagis , Respiratory Syncytial Virus , Market Size , The United Kingdom , Market Scenario , Market Assessment ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.